Original Article
Ultrasound contrast agent delivered per os first diagnoses pharyngoesophageal tumour
Authors:
E Antypa ,
Radiology Department, Evangelismos Hospital, Athens, Greece, GR
DD Cokkinos,
Radiology Department, Evangelismos Hospital, Athens, Greece, GR
I Kalogeropoulos,
Radiology Department, Evangelismos Hospital, Athens, Greece, GR
D Tomais,
Radiology Department, Evangelismos Hospital, Athens, Greece, GR
PN Piperopoulos
Radiology Department, Evangelismos Hospital, Athens, Greece, GR
Abstract
Oral administration of ultrasound contrast agents has been described very little so far in medical literature. These agents are mainly administered intravenously and, less commonly, intracavitarily. We present the case of a patient with a cervical mass in whom sonographic examination with per os administration of SonoVue led to the diagnosis of a pharyngoesophageal tumour. The diagnosis was confirmed on barium swallow and endoscopy-guided biopsy.
How to Cite:
Antypa E, Cokkinos D, Kalogeropoulos I, Tomais D, Piperopoulos P. Ultrasound contrast agent delivered per os first diagnoses pharyngoesophageal tumour. JBR-BTR. 2013;96(2):69–71. DOI: http://doi.org/10.5334/jbr-btr.211
Published on
01 Mar 2013.
Peer Reviewed
Downloads
